Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clal Finance Batucha Investment Management was a leading Israeli investment house and brokerage firm that operated as a subsidiary of Clal Finance. The company provided a comprehensive suite of financial services, including portfolio management, mutual fund administration, and securities trading on the Tel Aviv Stock Exchange. Formed through the integration of the Batucha brokerage firm into Clal Finance, it became one of the largest private investment entities in Israel. In 2013, the company's operations were acquired by Meitav Dash (now Meitav), marking its consolidation into one of the country's largest investment groups. While it was a significant institutional investor in the Israeli life sciences sector, it functioned primarily as a financial services provider rather than a biotechnology company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clal Finance Batucha Investment Management.